The suppressive role of GLS in radiosensitivity and irradiation-induced immune response in LUAD: integrating bioinformatics and experimental insights
In the contexts of radiotherapy, GLS downregulation exerts dual regulatory effects by modulating ferroptosis and remodeling the immune landscapes, particularly enhancing CD8<sup>+</sup> T cell cytotoxicity. Our work suggests that strategies preferentially targeting GLS in tumor cells may represent promising and translatable therapeutic approaches to promote antitumor efficacy of radiotherapy plus immune checkpoint blockade in LUAD patients. Furthermore, the established GLS-DSBr model serves as a robust predictive tool for prognosis and effects of radiotherapy and immunotherapy, which assists personalized treatment optimization in LUAD.
Authors
- Li Su (ORCID: https://orcid.org/0000-0002-4136-4770)
- Zhifeng Jiang (ORCID: https://orcid.org/0000-0001-5695-4522)
- Peicheng Jiang
- Ye‐Xiong Li (ORCID: https://orcid.org/0000-0003-0985-235X)
- Xinyan Li (ORCID: https://orcid.org/0000-0002-3005-0151)
- Yuqiong Chen (ORCID: https://orcid.org/0000-0001-7592-5989)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Fudan University (CN)
- Suzhou Municipal Hospital (CN)
- Zhongshan Hospital (CN)
- Shanghai Clinical Research Center (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1582587
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00